Mogelijk gemaakt door Google TranslateTranslate
Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Latest Press Releases
View all
TimeHeadline
6m agoSharon AI Appoints Mr. Andrew Penn as Chairman of the Board of Directors
7m agoBausch + Lomb to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
7m agoRigetti Signs Letter of Intent with U.S. Government for Quantum Computing Research
7m agoEuroseas Ltd. Reports Results for the Quarter Ended March 31, 2026 and Declares Quarterly Common Stock Dividend
7m agoGuardian Exploration Appoints Scott C. Pimm to Advisory Board to Strengthen Northern Infrastructure and Project Development Expertise
Genmab A/s logo

Genmab A/s

About

1,736.00DKK+13.50 +0.78%
Closed • Updated at 11:54 GMT+00:00
Market Cap$15.96B
P/E Ratio20.31
Volume35.3K
Beta0.55
RSI51.95
Gross Margin93.31%
Health TechnologyBiotechnology

Genmab A/s — investor relations, events, news, and company updates on 6ix.

Latest News

May 8 2026
Major Shareholder Announcement
May 7 2026
Genmab Announces Financial Results for the First Quarter of 2026
Apr 17 2026
Genmab A/S Share Capital Reduction
Apr 14 2026
Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2026
Apr 13 2026
Genmab Presents the Safety and Tolerability of Rinatabart Sesutecan (Rina-S®) in Combination with Bevacizumab in Advanced Ovarian Cancer

Community Chat

Ask AI

6ix6ixAIEvents